The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Goldline Pharmaceutical IPO
Goldline Pharmaceutical
SMEListed

Goldline Pharmaceutical IPO

Bidding 12-14 May 2026, price band ₹41–43, lot 3000 shares.

+38.95%
listing gain
OverviewGMPSubscriptionAllotment

Grey Market Premium Trend

GMP last updated: 19 May 2026, 9:31 AM IST

₹15
Final GMP
38.95%
Actual Listing Gain
34.9%
GMP-Implied Gain
₹41 - ₹43
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
18 May₹15₹5834.88%
17 May₹15₹5834.88%
16 May₹20₹6346.51%
15 May₹20₹6346.51%
14 May₹20₹6346.51%
13 May₹15₹5834.88%
12 May₹25₹6858.14%
11 May₹18₹6141.86%
10 May₹17₹6039.53%
9 May₹16₹5937.21%
8 May₹15₹5834.88%
7 May₹8₹5118.60%
6 May₹0₹430.00%

IPO timeline

  1. Issue open date
    12 May 2026
  2. Issue close date
    14 May 2026
  3. UPI mandate deadline
    14 May 2026
  4. Allotment finalization
    15 May 2026
  5. Refund initiation
    18 May 2026
  6. Share credit
    18 May 2026
  7. Listing date
    19 May 2026
  8. Mandate end date
    29 May 2026
  9. Lock-in end date for anchor investors (50%)
    13 Jun 2026
  10. Lock-in end date for anchor investors (remaining)
    12 Aug 2026

Goldline Pharmaceutical IPO Allotment Status

Allotment date:15 May 2026
Registrar:Bigshare Services Pvt Ltd
  1. Open the registrar's allotment page from the link below.
  2. Select Goldline Pharmaceutical from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Bigshare Services(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:18 May 2026
Shares credited to demat:18 May 2026
Listing:19 May 2026
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)1661.37🔥<0.01%
bHNI1995.14🔥<0.01%
sHNI993.83🔥0.10%
QIBs180.22🔥-
Retail876.55🔥0.11%
Total838.33🔥-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 14 May'26 04:43PM

Quick Stats

Issue Size:12cr
Lot Size:3000 shares
Min Investment (2 lots):₹2,58,000
P/E Ratio:10.47

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Goldline Pharmaceutical Limited is a pharmaceutical marketing and distribution company that sells products under the “Goldline” brand in India. The company operates through five product categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife and Goldline Wellness, which cater to therapeutic areas such as cardiology, diabetology, orthopaedics, paediatrics, critical care and supportive cancer care. The company does not manufacture products in-house and instead follows a third-party manufacturing model through contract manufacturers that comply with regulatory and quality standards. Its revenue is primarily generated from the sale and distribution of pharmaceutical products and related material supply and procurement support services. Goldline focuses on expanding its product portfolio and market reach through marketing and distribution activities while leveraging external manufacturers for production and formulation support.

Strengths

  • The company offers pharmaceutical products across five different business segments and therapies.
  • Goldline Pharmaceutical has a wide product portfolio catering to physicians, cardiologists, paediatricians, and critical care specialists.
  • The company follows an asset-light business model by outsourcing manufacturing to third-party manufacturers.
  • The company works with multiple contract manufacturers to support product manufacturing and supply.
  • The company focuses on marketing and distribution, helping expand its reach in the pharmaceutical market.

Risks

  • The company is fully dependent on third-party manufacturers for the production of its products.
  • Any delay or quality issue from contract manufacturers may affect the company’s business operations.
  • The company does not have its own research and development facility.
  • The company has faced delays in statutory filings and GST payments in the past.
  • The business depends heavily on distributors for a significant share of its revenue.

Goldline Pharmaceutical IPO – Frequently Asked Questions

  • The price band for the Goldline Pharmaceutical IPO is set at ₹41 to ₹43 per share.
  • The Goldline Pharmaceutical IPO opens on May 12, 2026 and closes on May 14, 2026.
  • The tentative listing date for the Goldline Pharmaceutical IPO is May 19, 2026.
  • The last recorded Grey Market Premium (GMP) for the Goldline Pharmaceutical IPO before listing was ₹15 (34.88%). GMP is unofficial and is not a guarantee of the listing price.
  • The Goldline Pharmaceutical IPO listed on May 19, 2026 with a listing gain of 38.95% over its issue price.
  • The Goldline Pharmaceutical IPO allotment date is May 15, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Bigshare Services Pvt Ltd. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Goldline Pharmaceutical IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Goldline Pharmaceutical, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Goldline Pharmaceutical IPO is 3000 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 6000 shares), which costs ₹2,58,000 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in May 2026